IEEE/ACM Transactions on Computational Biology and Bioinformatics,
Journal Year:
2024,
Volume and Issue:
21(5), P. 1211 - 1230
Published: March 18, 2024
Dynamic
disease
pathways
are
a
combination
of
complex
dynamical
processes
among
bio-molecules
in
cell
that
leads
to
diseases.
Network
modeling
considers
disease-related
(e.g.
DNA,
RNA,
transcription
factors,
enzymes,
proteins,
and
metabolites)
their
interaction
DNA
methylation,
histone
modification,
alternative
splicing,
protein
modification)
study
progression
predict
therapeutic
responses.
These
interactions
the
basic
elements
misregulation
gene
expression
lead
abnormal
cellular
Gene
regulatory
networks,
signaling
metabolic
networks
three
major
types
intracellular
for
responses
elicited
from
extracellular
signals.
The
can
be
prevented
or
regulated
by
designing
control
strategies
manipulate
these
other
paper
reviews
mechanisms,
dynamic
models,
each
network.
applications,
limitations
prospective
also
discussed.
Biochemical Journal,
Journal Year:
2023,
Volume and Issue:
480(1), P. 1 - 23
Published: Jan. 6, 2023
RAS
proteins
regulate
most
aspects
of
cellular
physiology.
They
are
mutated
in
30%
human
cancers
and
4%
developmental
disorders
termed
Rasopathies.
cycle
between
active
GTP-bound
inactive
GDP-bound
states.
When
active,
they
can
interact
with
a
wide
range
effectors
that
control
fundamental
biochemical
biological
processes.
Emerging
evidence
suggests
not
simple
on/off
switches
but
sophisticated
information
processing
devices
compute
cell
fate
decisions
by
integrating
external
internal
cues.
A
critical
component
this
function
is
the
dynamic
regulation
activation
downstream
signaling
allows
to
produce
rich
nuanced
spectrum
outputs.
We
discuss
recent
findings
how
dynamics
its
regulated.
Starting
from
structural
properties
wild-type
mutant
their
cycle,
we
examine
higher
molecular
assemblies,
effector
interactions
outputs,
all
under
aspect
regulation.
also
consider
computational
mathematical
modeling
approaches
contribute
analyze
understand
pleiotropic
functions
health
disease.
The Journal of Cell Biology,
Journal Year:
2022,
Volume and Issue:
221(6)
Published: April 14, 2022
Targeted
and
specific
induction
of
cell
death
in
an
individual
or
groups
cells
hold
the
potential
for
new
insights
into
response
tissues
organisms
to
different
forms
death.
Here,
we
report
development
optogenetically
controlled
effectors
(optoCDEs),
a
novel
class
optogenetic
tools
that
enables
light-mediated
three
types
programmed
(PCD)—apoptosis,
pyroptosis,
necroptosis—using
Arabidopsis
thaliana
photosensitive
protein
Cryptochrome-2.
OptoCDEs
enable
rapid
highly
PCD
human,
mouse,
zebrafish
are
suitable
wide
range
applications,
such
as
sub-lethal
precise
elimination
single
populations
vitro
vivo.
As
proof-of-concept,
utilize
optoCDEs
assess
differences
neighboring
responses
apoptotic
necrotic
PCD,
revealing
role
shingosine-1-phosphate
signaling
regulating
efferocytosis
by
epithelia.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 8, 2024
Abstract
Gene
expression
is
inherently
dynamic,
due
to
complex
regulation
and
stochastic
biochemical
events.
However,
the
effects
of
these
dynamics
on
cell
phenotypes
can
be
difficult
determine.
Researchers
have
historically
been
limited
passive
observations
natural
dynamics,
which
preclude
studies
elusive
noisy
cellular
events
where
large
amounts
data
are
required
reveal
statistically
significant
effects.
Here,
using
recent
advances
in
fields
machine
learning
control
theory,
we
train
a
deep
neural
network
accurately
predict
response
an
optogenetic
system
Escherichia
coli
cells.
We
then
use
model
predictive
framework
impose
arbitrary
cell-specific
gene
thousands
single
cells
real
time,
applying
generate
time-varying
patterns.
also
showcase
framework’s
ability
link
patterns
dynamic
functional
outcomes
by
controlling
tetA
antibiotic
resistance
gene.
This
study
highlights
how
learning-enabled
feedback
used
tailor
distributions
with
high
accuracy
throughput
without
expert
knowledge
biological
system.
Journal of Medicinal Chemistry,
Journal Year:
2022,
Volume and Issue:
65(20), P. 13561 - 13573
Published: Oct. 7, 2022
Extracellular
signal-regulated
protein
kinase
1/2
(ERK1/2),
the
only
known
substrate
of
MEK1/2,
is
located
downstream
RAS-RAF-MEK-ERK
(MAPK)
pathway
and
associated
with
abnormal
activation
poor
prognosis
cancer.
To
date,
several
small-molecule
inhibitors
RAS,
RAF,
MEK
have
been
reported
to
make
rapid
advances
in
cancer
therapy;
however,
acquired
resistance
still
occurs,
thereby
weakening
therapeutic
efficacy
these
inhibitors.
Recently,
selective
inhibition
ERK1/2
has
regarded
as
a
potential
strategy
that
can
not
effectively
block
MAPK
but
also
overcome
drug
caused
by
upstream
mutations
MEK.
Herein,
we
summarize
oncogenic
roles,
key
signaling
network,
single-
dual-target
preclinical
clinical
trials.
Together,
inspiring
findings
shed
new
light
on
discovery
more
candidate
drugs
improve
therapeutics.
Cell Reports,
Journal Year:
2023,
Volume and Issue:
42(6), P. 112570 - 112570
Published: May 29, 2023
The
combination
of
BRAF
and
MEK
inhibitors
(BRAFi/MEKi)
has
shown
promising
response
rates
in
treating
BRAF-mutant
melanoma
by
inhibiting
ERK
activation.
However,
treatment
efficacy
is
limited
the
emergence
drug-tolerant
persister
cells
(persisters).
Here,
we
show
that
magnitude
duration
receptor
tyrosine
kinase
(RTK)
activation
determine
reactivation
development.
Our
single-cell
analysis
reveals
only
a
small
subset
exhibits
effective
RTK
develops
persisters,
despite
uniform
external
stimuli.
kinetics
directly
influence
signaling
dynamics
These
initially
rare
persisters
form
major
resistant
clones
through
RTK-mediated
Consequently,
limiting
suppresses
cell
proliferation
drug-resistant
cells.
findings
provide
non-genetic
mechanistic
insights
into
role
heterogeneity
BRAFi/MEKi
resistance,
suggesting
potential
strategies
for
overcoming
drug
resistance
melanoma.
Developmental Cell,
Journal Year:
2023,
Volume and Issue:
58(23), P. 2802 - 2818.e5
Published: Sept. 15, 2023
Extracellular
signal-regulated
kinase
(Erk)
signaling
dynamics
elicit
distinct
cellular
responses
in
a
variety
of
contexts.
The
early
zebrafish
embryo
is
an
ideal
model
to
explore
the
role
Erk
vivo,
as
gradient
activated
diphosphorylated
(P-Erk)
induced
by
fibroblast
growth
factor
(Fgf)
at
blastula
margin.
Here,
we
describe
improved
Erk-specific
biosensor,
which
term
modified
translocation
reporter
(modErk-KTR).
We
demonstrate
utility
this
biosensor
vitro
and
developing
Drosophila
embryos.
Moreover,
show
that
Fgf/Erk
dynamic
coupled
tissue
during
both
development.
activity
rapidly
extinguished
just
prior
mitosis,
refer
mitotic
erasure,
inducing
periods
inactivity,
thus
providing
source
heterogeneity
asynchronously
dividing
tissue.
Our
transgenic
lines
represent
important
resource
for
interrogating
vivo.